Pharma News & Articles

1 Praise and perils for biotechnology patent policy Full Text Applied Clinical Trials, June 19, 2013

2 Valeant pharmaceuticals prices public offering of common shares Full Text Valeant Pharmaceuticals International, June 19, 2013

3 Mylan specialty L.P. joins forces with Adrian Peterson and JO frost to launch anaphylaxis preparedness campaign Full Text Mylan, June 19, 2013

4 Actavis files registration statement on form s-4 in connection with proposed warner chilcott acquisition Full Text Actavis, June 19, 2013

5 Announcement under Irish takeover rules revision to relevant securities in issue Full Text Warner Chilcott, June 19, 2013

6 Elan advises shareholders to withdraw any acceptances of the royalty pharma offer and not to tender any further acceptances into this lapsed offer Full Text Elan, June 19, 2013

7 Boston scientific vercise DBS system demonstrates improvement in motor function for patients with parkinsons disease Full Text Boston Scientific, June 19, 2013

8 Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis b virus patients Antimicrobial Agents and Chemotherapy, June 19, 2013    Clinical Article

9 Progress in structure-based design of EGFR inhibitors Current Drug Targets, June 19, 2013    Review Article

10 CTI announces new data presented at EHA 2013 congress demonstrating the safety and tolerability profile of pacritinib in patients with myelofibrosis Full Text Cell Therapeutics, June 19, 2013

11 GSK receives offer for its thrombosis brands and related manufacturing site Full Text GlaxoSmithKline, June 19, 2013

12 Sanofi to present new clinical data, including results from the investigational new insulin u300, at the american diabetes association 73rd scientific sessions Full Text Sanofi, June 19, 2013

13 Transaction in own shares Full Text Shire, June 19, 2013

14 Ariad honored with gold Stevie awards as pharmaceutical company of the year at 2013 American Business Awards Full Text ARIAD Pharmaceuticals, June 19, 2013

15 Covidien PLC to report third-quarter results on august 1, 2013 Full Text Covidien, June 19, 2013

16 Mylan announces pricing of senior notes Full Text Mylan, June 19, 2013

17 Bristol-myers squibb and abbvie announce progression-free survival data from phase 2 open-label study of investigational agent elotuzumab in combination with lenalidimide and dexamethasone in previously-treated multiple myeloma Full Text Bristol Myers-Squibb, June 19, 2013

18 Cytokinetics announces results from atomic-ahf will be presented at late breaking clinical trials session at the European society of cardiology congress 2013 Full Text Cytokinetics, June 19, 2013

19 Astrazeneca and bristol-myers squibb to present new data at american diabetes association 73rd scientific sessions Full Text Bristol Myers-Squibb, June 19, 2013

20 Quintiles named a "best place to work in it" by computerworld for fifth time Full Text Quintiles Transnational, June 19, 2013

1 Boehringer Ingelheim responds to fda warning letter Boehringer Ingelheim, May 23, 2013    Free full text

2 FDA announces compounding pharmacy recall American Hospital Association News, May 3, 2013    Free full text

3 FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease FDA Press Announcements, May 13, 2013    Free full text

4 Daratumumab Receives Breakthrough Therapy Designation from US Food and Drug Administration Genmab, May 6, 2013    Free full text

5 FDA approves ACTEMRA for children living with a rare form of arthritis Roche, May 2, 2013    Free full text

6 FDA alerts providers to recall by drug compounder American Hospital Association News, May 21, 2013    Free full text

7 FDA Approves Mercks LIPTRUZET (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol Merck, May 6, 2013    Free full text

8 FDA allows marketing of first a1c test labeled for diagnosing diabetes FDA Press Announcements, May 28, 2013    Free full text

9 Fda approves two drugs, companion diagnostic test for advanced skin cancer FDA Press Announcements, May 30, 2013    Free full text

10 FDA alerts providers to mattress cover safety risks American Hospital Association News, April 29, 2013    Free full text

11 Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy Lung Cancer, May 8, 2013    Review Article

12 Astellas pharma global development announces management reorganization Astellas, April 3, 2013    Free full text

13 FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death FDA What's New: Drugs, May 1, 2013    Free full text

14 FDA approves new drug for advanced prostate cancer FDA Press Announcements, May 17, 2013    Free full text

15 Providers pulling back on it outsourcing due to regulatory control Healthcare Informatics, May 24, 2013    Free full text

16 Should regulation of combination products become more centralized in Europe BioPharm International, May 24, 2013    Free full text

17 FDA warns consumers about potential health risk with Juices Incorporated juice products FDA Press Announcements, May 13, 2013    Free full text

18 Infliximab for Treatment-Resistant Depression First Report Managed Care, May 13, 2013    Free full text

19 Myriad to Present New Molecular Data for Patients With Prostate Cancer at the American Urological Association 2013 Annual Meeting Myriad Genetics, May 3, 2013    Free full text

20 PROVENGE (sipuleucel-T) Data Presented at An Annual Scientific Urology Meeting Dendreon Coproration, May 7, 2013    Free full text